Philadelphia, PA, United States of America

Christoph Wirblich

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Philadelphia, PA (US) (2021 - 2022)
  • Wernau, DE (2022 - 2023)

Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Christoph Wirblich: Innovator in Vaccine Development

Introduction

Christoph Wirblich is a prominent inventor based in Philadelphia, PA, who has made significant strides in the field of vaccine development. With a total of five patents to his name, Wirblich focuses on creating innovative solutions to combat viral infections, particularly those caused by rabies and coronaviruses. His work aims to enhance public health through advanced immunological research and applications.

Latest Patents

Wirblich's latest patents include groundbreaking methods and compositions for multivalent vaccines targeting both rabies virus and coronaviruses. The innovative technology aims to induce an immune response that offers dual protection against infections from these pathogens. Specifically, one notable patent discusses a recombinant rabies virus vector that encodes a fragment of coronavirus immunogenic glycoprotein, which can be used therapeutically to treat existing infections or to neutralize infecting agents. Additionally, he has developed a COVID-19 vaccine that incorporates a SARS-CoV-2 spike protein, facilitating new methods of immunization against the virus.

Career Highlights

Throughout his career, Christoph Wirblich has been associated with esteemed organizations, including Thomas Jefferson University and the Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services. His contributions to vaccination science have made a lasting impact in the field, illustrating his dedication to advancing medical research.

Collaborations

Wirblich has collaborated with renowned colleagues such as Matthias Johannes Schnell and Reed F. Johnson, which has further enriched his research endeavors. These partnerships have fostered a collaborative environment conducive to groundbreaking discoveries in virology and vaccine development.

Conclusion

Christoph Wirblich stands out as an influential inventor whose work on multivalent vaccines and COVID-19 solutions significantly contributes to the broader context of public health innovations. His dedication to developing effective vaccines showcases the vital role inventors play in addressing global health challenges. Through his patents and collaborations, Wirblich continues to pave the way for future advancements in immunology and vaccine research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…